N-of-1 Trials: Why Your Own Data Beats Population Averages
N-of-1 trials compare conditions within a single person over time. They're more informative for personal decisions than any population study — and you can run them yourself.
The Problem with "Works for Most People"
Imagine a clinical trial that finds a new sleep supplement reduces time-to-sleep by an average of 12 minutes across 400 participants. That sounds useful. But buried in the data is a distribution: some participants improved by 45 minutes, some by 5, and about 20% got worse. The average hides what you actually need to know: which group are you in?
This is not a flaw in how the study was run. It's a fundamental limitation of between-group research. When you average across people, you lose the individual signal. For population health decisions — setting drug approval thresholds, designing public health campaigns — group averages are exactly what you need. For deciding what you should do, they're often not enough.
N-of-1 trials are designed for exactly this problem.
What Is an N-of-1 Trial?
An N-of-1 trial is a controlled experiment with a single participant — you. Instead of comparing a treatment group to a control group across different people, it compares conditions within the same person across time.
The basic design is a crossover: you alternate between two conditions (say, treatment A and treatment B) across multiple periods, randomizing the order to control for time-based confounders. You measure an outcome each day. At the end, you compare your scores under condition A versus condition B.
Because you're your own control, many sources of between-person variation disappear. Your genetics, your baseline metabolism, your environment — these are held roughly constant. What varies is only the condition you're testing.
N-of-1 trials have a long history in medicine, particularly for chronic conditions where individual response to treatment varies widely. A 2011 paper in the Journal of Clinical Epidemiology called them "the most informative clinical trial design" for determining the best treatment for a specific patient.
Why Randomization Matters
The key feature that separates an N-of-1 trial from a careful diary is randomization. If you decide to test a new coffee brewing ratio and simply try it for two weeks, then go back to your old method for two weeks, you have no way to separate the effect of the intervention from the effect of time. Maybe you were stressed in week one and relaxed in week two. Maybe your taste preferences shifted. Maybe the placebo effect ran its course.
Randomizing which condition applies on a given day — by flipping a coin, rolling a die, or using an app — distributes these confounders roughly equally across conditions. It doesn't eliminate all sources of noise, but it prevents systematic bias.
This matters more than you might think. Human memory is terrible at self-assessment over time. We remember the peaks and the context, not the base rate. Randomization forces an honest comparison.
How Many Trials Do You Need?
Statistically, the more measurement periods you have, the more confident you can be in your conclusions. For most self-experiments with daily outcomes, 20–30 data points per condition is a reasonable target — that's 40–60 days of alternating conditions.
That sounds long. But consider: many people spend years wondering whether a habit is helping them, with no systematic data. Six to eight weeks of structured measurement often settles the question definitively.
For outcomes that change slowly (mood, energy, plant health), you might need longer. For outcomes that respond quickly (coffee taste rating, morning freshness after a sleep intervention), you can sometimes see reliable effects in 2–3 weeks.
A practical rule: don't stop early because you see an effect. Extend the experiment until you have enough data to trust it. Short experiments produce noisy conclusions.
Limitations to Keep in Mind
N-of-1 trials are not perfect. A few honest caveats:
Blinding is hard. In a pharmaceutical trial, patients can be blinded to whether they're getting the drug or placebo. In personal experiments, you usually know which condition you're in — especially for behavioral interventions like "go to bed at 10:30." This can create expectation effects. Where possible, use objective metrics (wearable data, logged performance scores) alongside subjective ones.
Carryover effects. Some interventions don't wash out quickly. If you test a high-fiber diet, residual effects might last days after you switch back to baseline. Build in washout periods between conditions when the intervention is likely to have lingering effects.
Single-person generalizability. Your results are valid for you. They may not apply to anyone else — which is precisely the point. Don't confuse your personal evidence with medical advice.
Putting It Together
An N-of-1 trial isn't complicated. You need:
- A specific question
- Two well-defined conditions
- A consistent, measurable outcome
- Random assignment to conditions each day (or each period)
- Enough data points to see a real signal
The experiment doesn't have to be perfect to be useful. A slightly noisy self-experiment that actually gets done is infinitely more valuable than a theoretically perfect design that never gets started.
Population studies tell you what might work for someone like you. An N-of-1 trial tells you what works for you — and that's what you actually need to know when making decisions about your own life.
Browse the experiment library to find a template worth running, or design your own from scratch.